Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib
(Q28263625)
scientific article
scientific article
Language:
Current Data About
Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib
| (P31) |
(Q13442814)
|
||||
| (P304) |
10-5
10-15 |
||||
| (P407) |
(Q1860)
|
||||
| (P433) |
suppl_3
|
||||
| (P478) |
9 Suppl 3
9 |
||||
| (P577) |
+2004-00-00T00:00:00Z
Thursday, June 3, 2004 |
||||
| (P921) |
(Q128581)
|
||||
| (P1433) |
(Q2122327)
|
||||
| (P1476) |
"Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib" (language: en)
"Dual Kinase Inhibition in the Treatment of Breast Cancer: Initial Experience with the EGFR/ErbB-2 Inhibitor Lapatinib" (language: en) |
||||
| (P2093) |
Howard A Burris
H. A. Burris
|
||||
| (P13046) |
(Q7318358)
|
other details
| aliases |
Dual Kinase Inhibition in the Treatment of Breast Cancer: Initial Experience with the EGFR/ErbB-2 Inhibitor Lapatinib |
| description | scientific article |
External Links
| (P356) |
10.1634/THEONCOLOGIST.9-SUPPL_3-10
|
| (P698) |
15163842
|